We would like to thank the following sponsors and exhibitors for their support of the Communicable Diseases Control Conference 2019.

Principle Sponsor

Office of Health Protection, Australian Government Department of Health

Dr Marcelle Noja, A/g Director, Global Health Protection Section
A: MDP 14 PO Box 9848, Canberra ACT 2601
T: 02 6289 5794

E: marcelle.noja@health.gov.au
W: http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-about.htm


The mission of the Office of Health Protection, in partnership with key stakeholders, is to protect the health of the Australian community through effective national leadership, coordination and regulation; and by building and sustaining the capacity and capability to prevent, prepare and respond to threats and risks to public health and safety arising from communicable diseases, natural disasters, acts of terrorism and other incidents.

Associate Sponsor


Angela Swinnerton
A: Level 15-18, 151 Clarence Street, Sydney NSW 2000
T: 02 9850 3333
W: www.pfizer.com.au/


Working Together for a Healthier World Ⓡ

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines. Our diversified global health care portfolio includes human biologic and small molecule medicines and vaccines, as well as many of the world’s best-known consumer products.

For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To find out more visit www.pfizer.com.au.

Support Sponsor


Helen dela Cruz, Government Vaccines Manager
A: 63 Poplar Road, Parkville VIC 3052
T: 03 9389 4868

E: Helen.DelaCruz@seqirus.com
W: www.seqirus.com.au


Seqirus, a CSL company, is a leading provider of essential vaccines and pharmaceuticals. We have served Australia’s healthcare needs for over a century and today we operate Australia’s only local manufacturing facility for seasonal and pandemic influenza vaccine. Seqirus produces a range of unique medicines in the National Interest, and also in-licences a broad range of paediatric and adult vaccines and specialty pharmaceutical products.

Affiliation Sponsor

The Peter Doherty Institute for Infection and Immunity

Jennifer Fagundes, Administrative Assistant - Doherty Directorate
A: 792 Elizabeth St, Melbourne VIC 3000
T: 8344 6564

E: jennifer.fagundes@unimelb.edu.au
W: www.doherty.edu.au


Finding solutions to prevent, treat and cure infectious diseases and understanding the complexities of microbes and the immune system requires innovative approaches and concentrated effort. This is why the University of Melbourne – a world leader in education, teaching and research excellence – and The Royal Melbourne Hospital – an internationally renowned institution providing outstanding care, research and learning – partnered to create the Peter Doherty Institute for Infection and Immunity (Doherty Institute); a centre of excellence where leading scientists and clinicians collaborate to improve human health globally.

Affiliation Sponsor


A: Locked Mail Bag 961, North Sydney, NSW 2059
T: 02 9391 9000

E: feedback@health.nsw.gov.au
W: www.health.nsw.gov.au


NSW Health is the largest health system in Australia, with 228 hospitals and around 117,047 staff. The purpose of
NSW Health is to plan the provision of comprehensive, balanced and coordinated health services to promote,
protect, develop, maintain and improve the health and wellbeing of the people of NSW. The NSW State Health
Plan provides an overarching framework to guide NSW Health to meet State and Premier’s Priorities, as well as its
statutory functions. The Plan ensures the system delivers the right care, in the right place, at the right time. In
2018-19, the NSW Health Budget was $25.1 billion, a hike of $3.4 billion on the previous year and 1.9 million
people received care in hospital and 2.9 million people attended an emergency department.

Affiliation Sponsor


Anil Singh-Prakash, Executive Officer

A: SPHCM, Level 3, Samuels Building, UNSW, Sydney NSW 2052
T: 02 9385 2446

E: a.prakash@unsw.edu.au
W: https://sphcm.med.unsw.edu.au/


The School of Public Health and Community Medicine (SPHCM) in Sydney at the University of New South Wales is a leading postgraduate educator in Australia and the Asia-Pacific region through our Masters programs in Public Health, International Public Health, Health Management and Infectious Diseases Intelligence, including a range of specialisations, dual degrees, and research degrees. All our Masters coursework programs are available fully online or face to face.  Infectious diseases is a major area of research and teaching strength at UNSW, and UNSW is the top ranked Australian university in infectious diseases research and in the top 50 in the world. We offer opportunities for internships in Australia and overseas. For senior health professionals, our Future Health Leaders program offers the opportunity to complete a professional doctorate while working. UNSW is part of the PLUS Alliance with Arizona State University and Kings College London. Students doing our degrees can choose subjects from ASU or KCL as part of our Global Learning Network.The Bachelor of International Public Health is a new fully online program which is designed to build and strengthen the international public health workforce. With courses available as part of Plus Alliance it is a unique experience and immerses students in a virtual global classroom, allowing students to study when and where they want.

Affiliation Sponsor


Birgit Beisner, Head, NIP Vaccines Business

A: Level 3, 436 Johnston Street, Abbotsford VIC 3067
T: 03 9721 6000

E: birgit.m.beisner@gsk.com
W: http://www.gsk.com

GSK is a global research-based pharmaceutical and healthcare company with a mission to improve the quality of human life.


Our vaccines business is one of the largest in the world. We produce paediatric and adult vaccines for a range of infectious diseases.


In Australia our vaccines portfolio helps prevent illnesses such as hepatitis, rotavirus, diphtheria, tetanus, whooping cough, measles, mumps, rubella, bacterial meningitis and influenza and we are a primary supplier of childhood vaccines to the National Immunisation Program (NIP).


The Benchmarque Group

John von Dadelszen, Partnerships Manager

A: Level 1, 176 Wellington Parade, East Melbourne VIC 3002
T: 1300 855 568

E: courses@benchmarquegroup.com.au
W: www.benchmarquegroup.com.au


The Benchmarque Group is a Registered Training Organisation (RTO. 21824) delivering a range of skills courses and programs to meet the needs of a broad range of health professionals across Australia.

Our focus is on the delivery of nationally accredited courses and programs designed to provide healthcare professionals with the opportunity to expand their skills and careers. We concentrate on skills and knowledge that can be immediately implemented in a vocational context. Visit www.benchmarquegroup.com.au for more information.


Dr Craig Dalton, Coordinator of Flutracking

A: HNE Population Health, Wallsend NSW 2287
T: 0409 927 320

E: craig.dalton@newcastle.edu.au
W: www.flutracking.net


Flutracking tracks influenza-like illness incidence and severity in over 50,000 Australians and New Zealanders every week in winter - please share Flutracking.net with your friends and colleagues and help us go viral!

Contact Us: events@phaa.net.au 

© 2023 by Public Health Association of Australia.